FARALLON CAPITAL MANAGEMENT LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,730,480
-61.4%
116,000
-48.4%
0.02%
-66.2%
Q4 2020$12,240,000
-22.2%
225,000
-59.1%
0.07%
-20.4%
Q3 2018$15,741,000
-31.5%
550,000
-34.5%
0.09%
-34.5%
Q2 2018$22,982,000
+67.6%
840,000
+29.2%
0.14%
+49.5%
Q1 2018$13,709,000
-37.4%
650,000
-43.0%
0.10%
-46.6%
Q4 2017$21,911,0001,140,0000.18%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders